Cancer-related fatigue. Neoplasm-related fatigue
Conditions
Interventions
Intervention 1: Intervention Group: In this group, patients will take one 200 µg capsule of Selenium Plus once daily for 2 weeks, after which they will complete the fatigue questionnaire. They will th
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 18 to 80 years of age To be able to read and write Definitive diagnosis of cancer which requires chemotherapy and has been confirmed with pathology findings and authenticated by an oncology subspecialist Not having another treatment regimen that has healing effect on fatigue To have cancer-related fatigue and score of 40 and above in fatigue questionnaire To tolerate oral medication To cooperate and agree with the study
Exclusion criteria
Exclusion criteria: Patients with known depression undergoing treatment Having anemia Having a disease that prevents patient from continuing participation in study When more than 20% of the questionnaire has not been completed Pregnancy and lactation Renal failure Taking medications such as baloxavir, marboxil, deferiprone, cabotegravir, bisphosphonate derivatives, bictegravir, dolutegravir, eltrombopag, trientine, raltegravir, penicillamine, elvitegravir Known allergy to selenium Hypothyroidism Skin cancer and individulas at high risk for developing squamous cell carcinoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cancer-related fatigue. Timepoint: Zero, 2 weeks, 4 weeks. Method of measurement: Multivariable questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Mansouri
Esfahan University of Medical Sciences
Outcome results
None listed